Aspen Aerogels, Inc. (NYSE:ASPN – Get Free Report) has been assigned a consensus rating of “Hold” from the seven analysts that are currently covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and three have assigned a buy rating to the company. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is $4.25.
A number of brokerages have recently commented on ASPN. Barclays cut their target price on shares of Aspen Aerogels from $4.00 to $3.00 and set an “underweight” rating on the stock in a report on Thursday, March 5th. Roth Mkm cut their target price on shares of Aspen Aerogels from $6.00 to $3.00 and set a “buy” rating on the stock in a report on Thursday, February 26th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Aspen Aerogels in a report on Friday, March 27th. Zacks Research raised shares of Aspen Aerogels from a “strong sell” rating to a “hold” rating in a report on Thursday, January 15th. Finally, TD Cowen cut their target price on shares of Aspen Aerogels from $7.00 to $6.00 and set a “buy” rating on the stock in a report on Thursday, February 26th.
Check Out Our Latest Stock Report on ASPN
Hedge Funds Weigh In On Aspen Aerogels
Aspen Aerogels Stock Down 6.2%
Shares of NYSE:ASPN opened at $3.31 on Wednesday. The company has a market capitalization of $274.17 million, a PE ratio of -0.70 and a beta of 2.90. The company has a current ratio of 3.90, a quick ratio of 3.29 and a debt-to-equity ratio of 0.34. Aspen Aerogels has a twelve month low of $2.30 and a twelve month high of $9.78. The firm has a 50 day simple moving average of $3.39 and a 200-day simple moving average of $4.24.
Aspen Aerogels (NYSE:ASPN – Get Free Report) last issued its quarterly earnings data on Wednesday, February 25th. The construction company reported ($0.34) earnings per share for the quarter, missing the consensus estimate of ($0.27) by ($0.07). The company had revenue of $41.34 million for the quarter, compared to analysts’ expectations of $44.25 million. Aspen Aerogels had a negative return on equity of 13.91% and a negative net margin of 143.69%.The firm’s quarterly revenue was down 66.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.14 EPS. Aspen Aerogels has set its Q1 2026 guidance at -0.280–0.240 EPS. On average, equities analysts predict that Aspen Aerogels will post 0.17 EPS for the current fiscal year.
About Aspen Aerogels
Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.
The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.
Read More
Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.
